Global Radiopharmaceutical Market Growth 2019-2024
Published On: March 2019
 
Report ID:372697
 
 
Pages: 161




Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.

The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.

Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.

According to this study, over the next five years the Radiopharmaceutical market will register a 8.7% CAGR in terms of revenue, the global market size will reach US$ 8120 million by 2024, from US$ 4940 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceutical business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical market by product type, application, key manufacturers and key regions and countries.

This study considers the Radiopharmaceutical value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Oncology

Cardiology

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Radiopharmaceutical consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Radiopharmaceutical market by identifying its various subsegments.

Focuses on the key global Radiopharmaceutical manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Radiopharmaceutical with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Radiopharmaceutical submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Radiopharmaceutical Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Radiopharmaceutical Consumption 2014-2024

2.1.2 Radiopharmaceutical Consumption CAGR by Region

2.2 Radiopharmaceutical Segment by Type

2.2.1 Actinium-225

2.2.2 Lutetium-177

2.2.3 Radium-223

2.2.4 Holmium-166

2.2.5 Other

2.3 Radiopharmaceutical Consumption by Type

2.3.1 Global Radiopharmaceutical Consumption Market Share by Type (2014-2019)

2.3.2 Global Radiopharmaceutical Revenue and Market Share by Type (2014-2019)

2.3.3 Global Radiopharmaceutical Sale Price by Type (2014-2019)

2.4 Radiopharmaceutical Segment by Application

2.4.1 Oncology

2.4.2 Cardiology

2.4.3 Other

2.5 Radiopharmaceutical Consumption by Application

2.5.1 Global Radiopharmaceutical Consumption Market Share by Application (2014-2019)

2.5.2 Global Radiopharmaceutical Value and Market Share by Application (2014-2019)

2.5.3 Global Radiopharmaceutical Sale Price by Application (2014-2019)

3 Global Radiopharmaceutical by Players

3.1 Global Radiopharmaceutical Sales Market Share by Players

3.1.1 Global Radiopharmaceutical Sales by Players (2017-2019)

3.1.2 Global Radiopharmaceutical Sales Market Share by Players (2017-2019)

3.2 Global Radiopharmaceutical Revenue Market Share by Players

3.2.1 Global Radiopharmaceutical Revenue by Players (2017-2019)

3.2.2 Global Radiopharmaceutical Revenue Market Share by Players (2017-2019)

3.3 Global Radiopharmaceutical Sale Price by Players

3.4 Global Radiopharmaceutical Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Radiopharmaceutical Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Radiopharmaceutical Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Radiopharmaceutical by Regions

4.1 Radiopharmaceutical by Regions

4.1.1 Global Radiopharmaceutical Consumption by Regions

4.1.2 Global Radiopharmaceutical Value by Regions

4.2 Americas Radiopharmaceutical Consumption Growth

4.3 APAC Radiopharmaceutical Consumption Growth

4.4 Europe Radiopharmaceutical Consumption Growth

4.5 Middle East & Africa Radiopharmaceutical Consumption Growth

5 Americas

5.1 Americas Radiopharmaceutical Consumption by Countries

5.1.1 Americas Radiopharmaceutical Consumption by Countries (2014-2019)

5.1.2 Americas Radiopharmaceutical Value by Countries (2014-2019)

5.2 Americas Radiopharmaceutical Consumption by Type

5.3 Americas Radiopharmaceutical Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Radiopharmaceutical Consumption by Countries

6.1.1 APAC Radiopharmaceutical Consumption by Countries (2014-2019)

6.1.2 APAC Radiopharmaceutical Value by Countries (2014-2019)

6.2 APAC Radiopharmaceutical Consumption by Type

6.3 APAC Radiopharmaceutical Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Radiopharmaceutical by Countries

7.1.1 Europe Radiopharmaceutical Consumption by Countries (2014-2019)

7.1.2 Europe Radiopharmaceutical Value by Countries (2014-2019)

7.2 Europe Radiopharmaceutical Consumption by Type

7.3 Europe Radiopharmaceutical Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Radiopharmaceutical by Countries

8.1.1 Middle East & Africa Radiopharmaceutical Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Radiopharmaceutical Value by Countries (2014-2019)

8.2 Middle East & Africa Radiopharmaceutical Consumption by Type

8.3 Middle East & Africa Radiopharmaceutical Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Radiopharmaceutical Distributors

10.3 Radiopharmaceutical Customer

11 Global Radiopharmaceutical Market Forecast

11.1 Global Radiopharmaceutical Consumption Forecast (2019-2024)

11.2 Global Radiopharmaceutical Forecast by Regions

11.2.1 Global Radiopharmaceutical Forecast by Regions (2019-2024)

11.2.2 Global Radiopharmaceutical Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Radiopharmaceutical Forecast by Type

11.8 Global Radiopharmaceutical Forecast by Application

12 Key Players Analysis

12.1 Bracco Imaging

12.1.1 Company Details

12.1.2 Radiopharmaceutical Product Offered

12.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Bracco Imaging News

12.2 Bayer

12.2.1 Company Details

12.2.2 Radiopharmaceutical Product Offered

12.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Bayer News

12.3 Mallinckrodt

12.3.1 Company Details

12.3.2 Radiopharmaceutical Product Offered

12.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Mallinckrodt News

12.4 Nordion

12.4.1 Company Details

12.4.2 Radiopharmaceutical Product Offered

12.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Nordion News

12.5 Triad Isotopes

12.5.1 Company Details

12.5.2 Radiopharmaceutical Product Offered

12.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Triad Isotopes News

12.6 Lantheus

12.6.1 Company Details

12.6.2 Radiopharmaceutical Product Offered

12.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Lantheus News

12.7 IBA Group

12.7.1 Company Details

12.7.2 Radiopharmaceutical Product Offered

12.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 IBA Group News

12.8 GE Healthcare

12.8.1 Company Details

12.8.2 Radiopharmaceutical Product Offered

12.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 GE Healthcare News

12.9 China Isotope & Radiation

12.9.1 Company Details

12.9.2 Radiopharmaceutical Product Offered

12.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 China Isotope & Radiation News

12.10 Jubilant Pharma

12.10.1 Company Details

12.10.2 Radiopharmaceutical Product Offered

12.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Jubilant Pharma News

12.11 Eli Lilly

12.12 Advanced Accelerator Applications

12.13 SIEMENS

12.14 Dongcheng

12.15 Navidea

13 Research Findings and Conclusion


List of Tables and Figures

Figure Picture of Radiopharmaceutical

Table Product Specifications of Radiopharmaceutical

Figure Radiopharmaceutical Report Years Considered

Figure Market Research Methodology

Figure Global Radiopharmaceutical Consumption Growth Rate 2014-2024 (M Doses)

Figure Global Radiopharmaceutical Value Growth Rate 2014-2024 ($ Millions)

Table Radiopharmaceutical Consumption CAGR by Region 2014-2024 ($ Millions)

Figure Product Picture of Actinium-225

Table Major Players of Actinium-225

Figure Product Picture of Lutetium-177

Table Major Players of Lutetium-177

Figure Product Picture of Radium-223

Table Major Players of Radium-223

Figure Product Picture of Holmium-166

Table Major Players of Holmium-166

Figure Product Picture of Other

Table Major Players of Other

Table Global Consumption Sales by Type (2014-2019)

Table Global Radiopharmaceutical Consumption Market Share by Type (2014-2019)

Figure Global Radiopharmaceutical Consumption Market Share by Type (2014-2019)

Table Global Radiopharmaceutical Revenue by Type (2014-2019) ($ million)

Table Global Radiopharmaceutical Value Market Share by Type (2014-2019) ($ Millions)

Figure Global Radiopharmaceutical Value Market Share by Type (2014-2019)

Table Global Radiopharmaceutical Sale Price by Type (2014-2019)

Figure Radiopharmaceutical Consumed in Oncology

Figure Global Radiopharmaceutical Market: Oncology (2014-2019) (M Doses)

Figure Global Radiopharmaceutical Market: Oncology (2014-2019) ($ Millions)

Figure Global Oncology YoY Growth ($ Millions)

Figure Radiopharmaceutical Consumed in Cardiology

Figure Global Radiopharmaceutical Market: Cardiology (2014-2019) (M Doses)

Figure Global Radiopharmaceutical Market: Cardiology (2014-2019) ($ Millions)

Figure Global Cardiology YoY Growth ($ Millions)

Figure Radiopharmaceutical Consumed in Other

Figure Global Radiopharmaceutical Market: Other (2014-2019) (M Doses)

Figure Global Radiopharmaceutical Market: Other (2014-2019) ($ Millions)

Figure Global Other YoY Growth ($ Millions)

Table Global Consumption Sales by Application (2014-2019)

Table Global Radiopharmaceutical Consumption Market Share by Application (2014-2019)

Figure Global Radiopharmaceutical Consumption Market Share by Application (2014-2019)

Table Global Radiopharmaceutical Value by Application (2014-2019)

Table Global Radiopharmaceutical Value Market Share by Application (2014-2019)

Figure Global Radiopharmaceutical Value Market Share by Application (2014-2019)

Table Global Radiopharmaceutical Sale Price by Application (2014-2019)

Table Global Radiopharmaceutical Sales by Players (2017-2019) (M Doses)

Table Global Radiopharmaceutical Sales Market Share by Players (2017-2019)

Figure Global Radiopharmaceutical Sales Market Share by Players in 2017

Figure Global Radiopharmaceutical Sales Market Share by Players in 2018

Table Global Radiopharmaceutical Revenue by Players (2017-2019) ($ Millions)

Table Global Radiopharmaceutical Revenue Market Share by Players (2017-2019)

Figure Global Radiopharmaceutical Revenue Market Share by Players in 2017

Figure Global Radiopharmaceutical Revenue Market Share by Players in 2018

Table Global Radiopharmaceutical Sale Price by Players (2017-2019)

Figure Global Radiopharmaceutical Sale Price by Players in 2018

Table Global Radiopharmaceutical Manufacturing Base Distribution and Sales Area by Players

Table Players Radiopharmaceutical Products Offered

Table Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table Global Radiopharmaceutical Consumption by Regions 2014-2019 (M Doses)

Table Global Radiopharmaceutical Consumption Market Share by Regions 2014-2019

Figure Global Radiopharmaceutical Consumption Market Share by Regions 2014-2019

Table Global Radiopharmaceutical Value by Regions 2014-2019 ($ Millions)

Table Global Radiopharmaceutical Value Market Share by Regions 2014-2019

Figure Global Radiopharmaceutical Value Market Share by Regions 2014-2019

Figure Americas Radiopharmaceutical Consumption 2014-2019 (M Doses)

Figure Americas Radiopharmaceutical Value 2014-2019 ($ Millions)

Figure APAC Radiopharmaceutical Consumption 2014-2019 (M Doses)

Figure APAC Radiopharmaceutical Value 2014-2019 ($ Millions)

Figure Europe Radiopharmaceutical Consumption 2014-2019 (M Doses)

Figure Europe Radiopharmaceutical Value 2014-2019 ($ Millions)

Figure Middle East & Africa Radiopharmaceutical Consumption 2014-2019 (M Doses)

Figure Middle East & Africa Radiopharmaceutical Value 2014-2019 ($ Millions)

Table Americas Radiopharmaceutical Consumption by Countries (2014-2019) (M Doses)

Table Americas Radiopharmaceutical Consumption Market Share by Countries (2014-2019)

Figure Americas Radiopharmaceutical Consumption Market Share by Countries in 2018

Table Americas Radiopharmaceutical Value by Countries (2014-2019) ($ Millions)

Table Americas Radiopharmaceutical Value Market Share by Countries (2014-2019)

Figure Americas Radiopharmaceutical Value Market Share by Countries in 2018

Table Americas Radiopharmaceutical Consumption by Type (2014-2019) (M Doses)

Table Americas Radiopharmaceutical Consumption Market Share by Type (2014-2019)

Figure Americas Radiopharmaceutical Consumption Market Share by Type in 2018

Table Americas Radiopharmaceutical Consumption by Application (2014-2019) (M Doses)

Table Americas Radiopharmaceutical Consumption Market Share by Application (2014-2019)

Figure Americas Radiopharmaceutical Consumption Market Share by Application in 2018

Figure United States Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure United States Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Canada Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Canada Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Mexico Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Mexico Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Table APAC Radiopharmaceutical Consumption by Countries (2014-2019) (M Doses)

Table APAC Radiopharmaceutical Consumption Market Share by Countries (2014-2019)

Figure APAC Radiopharmaceutical Consumption Market Share by Countries in 2018

Table APAC Radiopharmaceutical Value by Countries (2014-2019) ($ Millions)

Table APAC Radiopharmaceutical Value Market Share by Countries (2014-2019)

Figure APAC Radiopharmaceutical Value Market Share by Countries in 2018

Table APAC Radiopharmaceutical Consumption by Type (2014-2019) (M Doses)

Table APAC Radiopharmaceutical Consumption Market Share by Type (2014-2019)

Figure APAC Radiopharmaceutical Consumption Market Share by Type in 2018

Table APAC Radiopharmaceutical Consumption by Application (2014-2019) (M Doses)

Table APAC Radiopharmaceutical Consumption Market Share by Application (2014-2019)

Figure APAC Radiopharmaceutical Consumption Market Share by Application in 2018

Figure China Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure China Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Japan Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Japan Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Korea Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Korea Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Southeast Asia Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Southeast Asia Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure India Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure India Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Australia Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Australia Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Table Europe Radiopharmaceutical Consumption by Countries (2014-2019) (M Doses)

Table Europe Radiopharmaceutical Consumption Market Share by Countries (2014-2019)

Figure Europe Radiopharmaceutical Consumption Market Share by Countries in 2018

Table Europe Radiopharmaceutical Value by Countries (2014-2019) ($ Millions)

Table Europe Radiopharmaceutical Value Market Share by Countries (2014-2019)

Figure Europe Radiopharmaceutical Value Market Share by Countries in 2018

Table Europe Radiopharmaceutical Consumption by Type (2014-2019) (M Doses)

Table Europe Radiopharmaceutical Consumption Market Share by Type (2014-2019)

Figure Europe Radiopharmaceutical Consumption Market Share by Type in 2018

Table Europe Radiopharmaceutical Consumption by Application (2014-2019) (M Doses)

Table Europe Radiopharmaceutical Consumption Market Share by Application (2014-2019)

Figure Europe Radiopharmaceutical Consumption Market Share by Application in 2018

Figure Germany Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Germany Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure France Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure France Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure UK Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure UK Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Italy Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Italy Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Russia Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Russia Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Spain Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Spain Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Table Middle East & Africa Radiopharmaceutical Consumption by Countries (2014-2019) (M Doses)

Table Middle East & Africa Radiopharmaceutical Consumption Market Share by Countries (2014-2019)

Figure Middle East & Africa Radiopharmaceutical Consumption Market Share by Countries in 2018

Table Middle East & Africa Radiopharmaceutical Value by Countries (2014-2019) ($ Millions)

Table Middle East & Africa Radiopharmaceutical Value Market Share by Countries (2014-2019)

Figure Middle East & Africa Radiopharmaceutical Value Market Share by Countries in 2018

Table Middle East & Africa Radiopharmaceutical Consumption by Type (2014-2019) (M Doses)

Table Middle East & Africa Radiopharmaceutical Consumption Market Share by Type (2014-2019)

Figure Middle East & Africa Radiopharmaceutical Consumption Market Share by Type in 2018

Table Middle East & Africa Radiopharmaceutical Consumption by Application (2014-2019) (M Doses)

Table Middle East & Africa Radiopharmaceutical Consumption Market Share by Application (2014-2019)

Figure Middle East & Africa Radiopharmaceutical Consumption Market Share by Application in 2018

Figure Egypt Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Egypt Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure South Africa Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure South Africa Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Israel Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Israel Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure Turkey Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure Turkey Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Figure GCC Countries Radiopharmaceutical Consumption Growth 2014-2019 (M Doses)

Figure GCC Countries Radiopharmaceutical Value Growth 2014-2019 ($ Millions)

Table Radiopharmaceutical Distributors List

Table Radiopharmaceutical Customer List

Figure Global Radiopharmaceutical Consumption Growth Rate Forecast (2019-2024) (M Doses)

Figure Global Radiopharmaceutical Value Growth Rate Forecast (2019-2024) ($ Millions)

Table Global Radiopharmaceutical Consumption Forecast by Countries (2019-2024) (M Doses)

Table Global Radiopharmaceutical Consumption Market Forecast by Regions

Table Global Radiopharmaceutical Value Forecast by Countries (2019-2024) ($ Millions)

Table Global Radiopharmaceutical Value Market Share Forecast by Regions

Figure Americas Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Americas Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure APAC Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure APAC Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Europe Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Europe Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Middle East & Africa Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Middle East & Africa Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure United States Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure United States Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Canada Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Canada Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Mexico Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Mexico Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Brazil Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Brazil Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure China Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure China Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Japan Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Japan Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Korea Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Korea Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Southeast Asia Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Southeast Asia Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure India Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure India Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Australia Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Australia Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Germany Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Germany Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure France Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure France Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure UK Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure UK Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Italy Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Italy Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Russia Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Russia Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Spain Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Spain Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Egypt Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Egypt Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure South Africa Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure South Africa Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Israel Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Israel Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure Turkey Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure Turkey Radiopharmaceutical Value 2019-2024 ($ Millions)

Figure GCC Countries Radiopharmaceutical Consumption 2019-2024 (M Doses)

Figure GCC Countries Radiopharmaceutical Value 2019-2024 ($ Millions)

Table Global Radiopharmaceutical Consumption Forecast by Type (2019-2024) (M Doses)

Table Global Radiopharmaceutical Consumption Market Share Forecast by Type (2019-2024)

Table Global Radiopharmaceutical Value Forecast by Type (2019-2024) ($ Millions)

Table Global Radiopharmaceutical Value Market Share Forecast by Type (2019-2024)

Table Global Radiopharmaceutical Consumption Forecast by Application (2019-2024) (M Doses)

Table Global Radiopharmaceutical Consumption Market Share Forecast by Application (2019-2024)

Table Global Radiopharmaceutical Value Forecast by Application (2019-2024) ($ Millions)

Table Global Radiopharmaceutical Value Market Share Forecast by Application (2019-2024)

Table Bracco Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure Bracco Imaging Radiopharmaceutical Market Share (2017-2019)

Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure Bayer Radiopharmaceutical Market Share (2017-2019)

Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure Mallinckrodt Radiopharmaceutical Market Share (2017-2019)

Table Nordion Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure Nordion Radiopharmaceutical Market Share (2017-2019)

Table Triad Isotopes Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure Triad Isotopes Radiopharmaceutical Market Share (2017-2019)

Table Lantheus Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure Lantheus Radiopharmaceutical Market Share (2017-2019)

Table IBA Group Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure IBA Group Radiopharmaceutical Market Share (2017-2019)

Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure GE Healthcare Radiopharmaceutical Market Share (2017-2019)

Table China Isotope & Radiation Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure China Isotope & Radiation Radiopharmaceutical Market Share (2017-2019)

Table Jubilant Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)

Figure Jubilant Pharma Radiopharmaceutical Market Share (2017-2019)

Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Advanced Accelerator Applications Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table SIEMENS Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Dongcheng Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors



Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.